Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Director | Jan 29, 2023 | Option Exercise | $1.50 | 431 | 647 | 11,989 | Jan 31, 2023, 08:55 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 06, 2023 | Option Exercise | $1.30 | 11 | 14 | 12,420 | Jan 10, 2023, 05:56 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Dec 31, 2022 | Option Exercise | $1.89 | 5 | 9 | 12,431 | Jan 04, 2023, 06:09 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Dec 06, 2022 | Option Exercise | $2.02 | 9 | 18 | 12,436 | Dec 08, 2022, 04:34 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Nov 30, 2022 | Option Exercise | $2.25 | 5 | 11 | 12,445 | Dec 02, 2022, 05:15 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Nov 06, 2022 | Option Exercise | $2.24 | 10 | 22 | 12,450 | Nov 08, 2022, 05:24 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Oct 31, 2022 | Option Exercise | $2.54 | 5 | 13 | 12,460 | Nov 01, 2022, 05:08 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Oct 06, 2022 | Option Exercise | $2.72 | 9 | 24 | 12,465 | Oct 11, 2022, 05:03 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 30, 2022 | Option Exercise | $2.08 | 5 | 10 | 12,474 | Oct 04, 2022, 09:31 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 06, 2022 | Option Exercise | $0.16 | 225 | 35 | 311,977 | Sep 07, 2022, 06:00 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 31, 2022 | Option Exercise | $0.16 | 107 | 18 | 312,202 | Sep 01, 2022, 06:38 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 06, 2022 | Option Exercise | $0.18 | 225 | 42 | 312,309 | Aug 08, 2022, 05:44 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jul 31, 2022 | Option Exercise | $0.18 | 107 | 19 | 312,534 | Aug 03, 2022, 09:45 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jul 06, 2022 | Option Exercise | $0.18 | 225 | 41 | 312,641 | Jul 07, 2022, 04:11 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jun 30, 2022 | Option Exercise | $0.18 | 107 | 19 | 312,866 | Jul 01, 2022, 06:08 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jun 06, 2022 | Option Exercise | $0.20 | 225 | 45 | 312,973 | Jun 07, 2022, 04:47 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | May 31, 2022 | Option Exercise | $0.21 | 107 | 22 | 313,198 | Jun 02, 2022, 04:10 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | May 06, 2022 | Option Exercise | $0.26 | 225 | 58 | 313,305 | May 09, 2022, 06:32 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Apr 30, 2022 | Option Exercise | $0.31 | 107 | 33 | 313,530 | May 03, 2022, 04:59 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Apr 06, 2022 | Option Exercise | $0.41 | 219 | 90 | 313,637 | Apr 08, 2022, 04:16 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Mar 31, 2022 | Option Exercise | $0.42 | 104 | 44 | 313,856 | Apr 04, 2022, 06:27 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Mar 06, 2022 | Option Exercise | $0.43 | 263 | 113 | 313,960 | Mar 08, 2022, 04:12 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Feb 28, 2022 | Option Exercise | $0.45 | 125 | 56 | 314,223 | Mar 02, 2022, 07:51 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Feb 06, 2022 | Option Exercise | $0.48 | 263 | 126 | 314,348 | Feb 08, 2022, 04:25 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 29, 2022 | Option Exercise | $0.45 | 10,766 | 4,845 | 314,736 | Feb 01, 2022, 08:47 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 31, 2022 | Option Exercise | $0.48 | 125 | 60 | 314,611 | Feb 01, 2022, 08:47 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 06, 2022 | Option Exercise | $0.58 | 270 | 157 | 325,502 | Jan 10, 2022, 04:19 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Dec 28, 2021 | Buy | $0.57 | 100,000 | 57,320 | 325,879 | Dec 29, 2021, 09:32 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Dec 06, 2021 | Option Exercise | $0.72 | 225 | 162 | 225,879 | Dec 08, 2021, 05:14 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Nov 30, 2021 | Option Exercise | $0.78 | 107 | 83 | 226,104 | Dec 02, 2021, 06:31 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Nov 06, 2021 | Option Exercise | $1.33 | 225 | 299 | 226,211 | Nov 09, 2021, 05:38 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Oct 31, 2021 | Option Exercise | $1.15 | 107 | 123 | 226,436 | Nov 01, 2021, 07:51 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Oct 06, 2021 | Option Exercise | $1.08 | 225 | 243 | 226,543 | Oct 08, 2021, 04:39 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 30, 2021 | Option Exercise | $1.19 | 107 | 127 | 226,768 | Oct 04, 2021, 04:14 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 14, 2021 | Buy | $1.13 | 50,000 | 56,500 | 226,875 | Sep 15, 2021, 08:00 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 06, 2021 | Option Exercise | $1.11 | 225 | 250 | 176,875 | Sep 08, 2021, 05:27 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 31, 2021 | Option Exercise | $1.06 | 107 | 113 | 177,100 | Sep 02, 2021, 04:07 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 06, 2021 | Option Exercise | $1.17 | 225 | 263 | 177,207 | Aug 10, 2021, 05:16 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jul 31, 2021 | Option Exercise | $1.10 | 107 | 118 | 177,432 | Aug 03, 2021, 04:09 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jul 06, 2021 | Option Exercise | $1.27 | 225 | 286 | 177,539 | Jul 08, 2021, 04:11 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jun 30, 2021 | Option Exercise | $1.35 | 107 | 144 | 177,764 | Jul 02, 2021, 04:06 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | May 06, 2021 | Option Exercise | $1.49 | 225 | 335 | 178,203 | May 10, 2021, 05:53 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Apr 30, 2021 | Option Exercise | $1.78 | 107 | 190 | 178,428 | May 04, 2021, 04:03 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Feb 06, 2021 | Option Exercise | $2.90 | 2,695 | 7,816 | 178,985 | Apr 08, 2021, 09:48 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Mar 06, 2021 | Option Exercise | $1.79 | 225 | 403 | 178,760 | Apr 08, 2021, 09:48 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Apr 06, 2021 | Option Exercise | $1.73 | 225 | 389 | 178,535 | Apr 08, 2021, 09:48 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Feb 28, 2021 | Option Exercise | $2.39 | 106 | 253 | 181,787 | Mar 02, 2021, 07:42 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 31, 2021 | Option Exercise | $2.62 | 125 | 327 | 181,893 | Feb 02, 2021, 08:01 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Dec 31, 2020 | Option Exercise | $2.42 | 121 | 293 | 64,518 | Jan 05, 2021, 05:15 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Nov 30, 2020 | Option Exercise | $0.43 | 1,211 | 517 | 646,396 | Dec 01, 2020, 08:21 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Oct 31, 2020 | Option Exercise | $0.50 | 1,211 | 600 | 647,607 | Nov 02, 2020, 07:07 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 30, 2020 | Option Exercise | $0.53 | 1,211 | 645 | 648,818 | Oct 01, 2020, 04:32 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 31, 2020 | Option Exercise | $0.62 | 1,211 | 750 | 650,029 | Sep 02, 2020, 05:15 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jul 31, 2020 | Option Exercise | $0.76 | 1,211 | 920 | 651,240 | Aug 04, 2020, 04:08 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jun 30, 2020 | Option Exercise | $0.67 | 1,211 | 817 | 652,451 | Jul 02, 2020, 04:06 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | May 31, 2020 | Option Exercise | $1.14 | 1,211 | 1,381 | 653,662 | Jun 03, 2020, 06:07 AM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Apr 30, 2020 | Option Exercise | $0.55 | 1,211 | 664 | 648,686 | May 04, 2020, 06:31 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Mar 31, 2020 | Option Exercise | $0.57 | 1,211 | 696 | 649,897 | Apr 02, 2020, 05:48 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Feb 28, 2020 | Option Exercise | $1.35 | 1,211 | 1,635 | 651,108 | Mar 03, 2020, 09:32 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 31, 2020 | Option Exercise | $1.35 | 16,276 | 21,973 | 302,760 | Feb 04, 2020, 08:55 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 27, 2019 | Buy | $1.79 | 50,000 | 89,500 | 117,489 | Aug 28, 2019, 04:01 PM | |
HPTX | HYPERION THERAPEUTICS INC | Schroeder Theodore R | Director | May 07, 2015 | Option Exercise | $46.00 | 3,700 | 170,200 | 0 | May 08, 2015, 07:58 PM | |
CADX | CADENCE PHARMACEUTICALS INC | Schroeder Theodore R | President, CEO | Mar 19, 2014 | Option Exercise | $14.00 | 12,664 | 177,296 | 0 | Mar 21, 2014, 01:28 PM | |
CADX | CADENCE PHARMACEUTICALS INC | Schroeder Theodore R | President, CEO | Mar 19, 2014 | Option Exercise | $14.00 | 307,500 | 4,305,000 | 0 | Mar 21, 2014, 01:28 PM | |
CADX | CADENCE PHARMACEUTICALS INC | Schroeder Theodore R | President, CEO | Nov 02, 2011 | Option Exercise | $5.72 | 7,336 | 41,962 | 12,664 | Nov 04, 2011, 04:45 PM | |
CADX | CADENCE PHARMACEUTICALS INC | Schroeder Theodore R | President, CEO | May 17, 2011 | Buy | $7.48 | 16,000 | 119,626 | 307,500 | May 17, 2011, 06:18 PM | |
CADX | CADENCE PHARMACEUTICALS INC | Schroeder Theodore R | President, CEO | Sep 30, 2010 | Sale | $8.35 | 40,703 | 339,691 | 320,297 | Oct 04, 2010, 04:16 PM | |
CADX | CADENCE PHARMACEUTICALS INC | Schroeder Theodore R | President, CEO | Oct 01, 2010 | Sale | $8.35 | 9,297 | 77,670 | 311,000 | Oct 04, 2010, 04:16 PM |